Clinical features and treatment outcome of very elderly patients over 80 years old with multiple myeloma: comparison with patients in different age groups in the era of novel agents

Kosei MatsueDivision of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, JapanCorrespondence[email protected]

Yuya MatsueDepartment of Cardiology, University Medical Center Groninge, Groninge, The Netherlands

Manabu FujisawaDivision of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Japan

Kota FukumotoDivision of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Japan

Yasuhito SueharaDivision of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Japan

Hiroki SugiharaDivision of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Japan

Masami TakeuchiDivision of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Japan

Your download is now in progress and you may close this window